Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis.

Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis. Abstract Text:

Stefan O Ciurea,Delwin Merchant,Nadim Mahmud,Takefumi Ishii,Yan Zhao,Wenyang Hu,Edward Bruno,Giovanni Barosi,Mingjiang Xu,Ronald Hoffman,

Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis. Publishing Authors By Initials

SO Ciurea,D Merchant,N Mahmud,T Ishii,Y Zhao,W Hu,E Bruno,G Barosi,M Xu,R Hoffman,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis. Journal Published:

PUBLICATION TYPE: Letter

Journal: Blood

VOLUME: 110

Page Numbers: 3085-6

Journal Abbreviation: Blood

ISSN: 0006-4971

DAY: 15

MONTH: Oct

YEAR: 2007

Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7603509

Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Blood

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis Related Publications

• Adrenal cortical steroids in the treatment of surgical shock.
• Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.
• Battling the hematological malignancies: the 200 years' war.
• CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
• Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis.
• Clinical pharmacology of cancer therapies in older adults.
• Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart.
• Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
• Evaluation of fatty acid amides in the carrageenan-induced paw edema model.
• Exposure to marijuana smoke impairs memory retrieval in mice.
• Hydroxyurea-induced cutaneous ulceration in older patients.
• IL-4 enhances IL-10 gene expression in murine Th2 cells in the absence of TCR engagement.
• IN VITRO PORPHOBILINOGEN AND PORPHYRIN SYNTHESIS IN THALASSEMIA MAJOR AND SICKLE CELL ANEMIA.
• Imaging the neuromuscular junction over the past centuries ?
• Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.
• In vivo imaging of presynaptic terminals and postsynaptic sites in the mouse submandibular ganglion.
• Is There an Entity of Chemically Induced BCR-ABL-Positive Chronic Myelogenous Leukemia?
• Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine.
• Lysosomal activity associated with developmental axon pruning.
• Pharmacokinetics of chemotherapy in the older patient.
• Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.
• Rapid and modifiable neurotransmitter receptor dynamics at a neuronal synapse in vivo.
• Targeting interferon-gamma to treat atherosclerosis.
• The cannabinoid CB(1) receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task.
• The influence of the regulatory T lymphocytes on atherosclerosis.
• The uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist memantine prolongs spatial memory in a rat delayed radial-arm maze memory task.
• Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system.